共 50 条
- [21] 2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential [J]. Supportive Care in Cancer, 2024, 32
- [24] 2023 Updated MASCC/ESMO Consensus Recommendations: prevention of radiotherapy- and chemoradiotherapy-induced nausea and vomiting [J]. Supportive Care in Cancer, 2024, 32
- [26] 2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agents [J]. Supportive Care in Cancer, 2024, 32
- [27] 2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents [J]. Supportive Care in Cancer, 2024, 32
- [29] 2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting [J]. Supportive Care in Cancer, 2024, 32